Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

MAA validated for emtricitabine/rilpivirine/tenofovir combination tablet

Aug. 21, 2015

ExeGi Pharma announces clinical trial of probiotic Visbiome in HIV infection

Aug. 21, 2015

Long-term LATTE results show HIV suppression with two-drug cabotegravir plus rilpivirine regimen

Aug. 20, 2015

Discovery and optimization of novel HIV integrase inhibitors from BMS

Aug. 19, 2015

Pseudo-glycodendrimer blocks HIV transinfection

Aug. 7, 2015

RNA vaccine iHIVARNA-01 enters phase I trial in patients with HIV-1 infection

July 30, 2015

Preliminary phase II results presented for VAC-3S HIV vaccine

July 29, 2015

Prevention of HIV transcription from latency by Tat inhibitor

July 23, 2015

FDA grants breakthrough therapy designation to BMS-663068

July 22, 2015

European Commission approves Evotaz for HIV-1 infection in adults

July 17, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...